Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q2

3055.TEDINET S100PK8H
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥129.4bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥122.0bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥1.1bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥759m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥1.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥2.1bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥1.7bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.2bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥140.6bnat 2022-09-30Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥137.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥83.9bnat 2022-09-30Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥56.6bnat 2022-09-30Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥55.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥21.4bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.6bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥122m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥224m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥633m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥648m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥62.942022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.062021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.172021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio40.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.5%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥30m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥910m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥848m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥217m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥631m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥20m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥33.0bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥32.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥251m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥777m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥172m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥92.3bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥87.7bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥347m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥136.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥129.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥2.2bn
Otherother segmentsrevenue2021-04-01 → 2021-09-30¥1.0bn
Otherother segmentsrevenue external2021-04-01 → 2021-09-30¥30m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥991m
Otherother segmentssegment profit2021-04-01 → 2021-09-30¥345m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥7m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥40m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥675m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥217m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥457m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥28m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥30.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥30.4bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥237m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥572m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥1.9bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.9bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥157m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-09-30¥87.2bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-09-30¥82.8bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-09-30¥113m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥128.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥122.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 550
ItemContextValueUnit
Net salesPrior1YTDDuration122032000000JPY
Net salesCurrentYTDDuration129371000000JPY
Cost of salesPrior1YTDDuration112904000000JPY
Cost of salesCurrentYTDDuration119667000000JPY
Gross profitPrior1YTDDuration9127000000JPY
Gross profitCurrentYTDDuration9703000000JPY
Packing expenses sgaPrior1YTDDuration544000000JPY
Packing expenses sgaCurrentYTDDuration535000000JPY
Salaries sgaPrior1YTDDuration3790000000JPY
Salaries sgaCurrentYTDDuration3883000000JPY
Provision for bonuses sgaPrior1YTDDuration846000000JPY
Provision for bonuses sgaCurrentYTDDuration865000000JPY
Provision for directors bonuses sgaPrior1YTDDuration56000000JPY
Provision for directors bonuses sgaCurrentYTDDuration56000000JPY
Retirement benefit expenses sgaPrior1YTDDuration178000000JPY
Retirement benefit expenses sgaCurrentYTDDuration187000000JPY
Legal and employee benefits expenses sgaPrior1YTDDuration784000000JPY
Legal and employee benefits expenses sgaCurrentYTDDuration784000000JPY
Rent expenses sgaPrior1YTDDuration143000000JPY
Rent expenses sgaCurrentYTDDuration144000000JPY
Other sgaPrior1YTDDuration2023000000JPY
Other sgaCurrentYTDDuration2146000000JPY
Selling general and administrative expensesPrior1YTDDuration8368000000JPY
Selling general and administrative expensesCurrentYTDDuration8603000000JPY
Operating incomePrior1YTDDuration759000000JPY
Operating incomeCurrentYTDDuration1099000000JPY
Interest income noiPrior1YTDDuration2000000JPY
Interest income noiCurrentYTDDuration2000000JPY
Dividends income noiPrior1YTDDuration149000000JPY
Dividends income noiCurrentYTDDuration156000000JPY
Office work fee noiPrior1YTDDuration273000000JPY
Office work fee noiCurrentYTDDuration279000000JPY
Real estate rent noiPrior1YTDDuration67000000JPY
Real estate rent noiCurrentYTDDuration71000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration55000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration54000000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration38000000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration17000000JPY
Other noiPrior1YTDDuration108000000JPY
Other noiCurrentYTDDuration107000000JPY
Non operating incomePrior1YTDDuration695000000JPY
Non operating incomeCurrentYTDDuration689000000JPY
Interest expenses noePrior1YTDDuration0JPY
Interest expenses noeCurrentYTDDuration0JPY
Rent cost of real estate noePrior1YTDDuration53000000JPY
Rent cost of real estate noeCurrentYTDDuration58000000JPY
Cost of idle assets noePrior1YTDDuration12000000JPY
Cost of idle assets noeCurrentYTDDuration8000000JPY
Other noePrior1YTDDuration19000000JPY
Other noeCurrentYTDDuration6000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass